Eicosapentaenoic Acid for Cardiovascular Events Reduction- Systematic Review and Network Meta-Analysis of Randomized Controlled Trials

CONCLUSIONS: Our analyses demonstrate that although EPA supplementation lowers risk of coronary revascularization more than other oils, there may not be a benefit relative to standard of care. Further, EPA reduces the risk of cardiovascular events only in comparison to mineral oil and not when compared with other placebo oils or controls. In contrast, combined EPA+DHA was associated with reduced risk of cardiovascular death compared to controls.PMID:35914996 | DOI:10.1016/j.jjcc.2022.07.008

Source: Journal of Cardiology - August 1, 2022 Category: Cardiology Authors: Yujiro Yokoyama Toshiki Kuno Sae X Morita Leandro Slipczuk Hisato Takagi Alexandros Briasoulis Azeem Latib Sripal Bangalore Sean P Heffron Source Type: research